Atrial fibrillation (also called AF or A Fib ) is the most common form of sustained arrhythmia (heart rhythm disorder). Atrial fibrillation is more common in older people, people with high blood pressure, and people with other kinds of heart disease. It can lead to serious health problems such as stroke, fatigue, and heart failure. The January 27, 2010, issue of JAMA includes an article about treatments for atrial fibrillation. This Patient Page is based on one previously published in the December 19, 2007, issue of JAMA.
Atrial fibrillation occurs when the electrical impulses that cause the heart to beat in a regular rhythmic manner become disorganized, causing the heart to beat irregularly and often too fast with too little force. The irregular pulse can be felt and can be seen on an electrocardiogram. An electrocardiogram (ECG or EKG ) is a recording of the electrical activity of the heart made from electrodes (electrical conductors) placed on the surface of the skin, usually on each arm and leg and across the chest. On a normal ECG, the electrical activity of the heart appears as regular peaks and valleys. On an ECG of a person with atrial fibrillation, the peaks and valleys are not regular and often are closer together, representing a faster heartbeat. Atrial fibrillation decreases the efficiency of the pumping action of the heart. It also increases the risk of formation of blood clots inside the heart. These blood clots can break off and go to other parts of the body, including the brain, where they can cause a stroke.
Grahic Jump Location
Some people with atrial fibrillation may not experience any symptoms at all. Others report feeling palpitations (a sensation of the heart "flopping") or may have chest discomfort or dizziness. A few people develop sudden and severe shortness of breath.
The two most important treatment goals involve slowing the heart rate to improve heart pumping efficiency and using anticoagulants (blood thinners) to prevent stroke.
Beta-blockers and calcium channel blockers are types of medication that can slow the heart rate.
Warfarin and aspirin are blood thinners. Warfarin is more effective in preventing strokes but can lead to bleeding and requires careful medical supervision.
Electrical cardioversion is a procedure that can reestablish regular rhythm for patients with severe symptoms. The patient is sedated and an electrical charge is given to the heart through the chest. Antiarrhythmic drugs may also be administered.
Other procedures involving surgery or use of a catheter (a tube inserted into the heart through a blood vessel) are available for individuals with symptoms due to atrial fibrillation.
American Heart Associationhttp://www.americanheart.org
National Heart, Lung, and Blood Institutehttp://www.nhlbi.nih.gov
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. A Patient Page on electrocardiograms was published in the September 13, 2006, issue.
Sources: American College of Cardiology; National Heart, Lung, and Blood Institute; American Heart Association
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.
TOPIC: HEART DISEASE
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
Users' Guides to the Medical Literature Clinical Resolution
Users' Guides to the Medical Literature Clinical Scenario
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.